protein C2orf66: A potential drug target and biomarker (G401027)

Target Name: C2orf66

NCBI ID: G401027

C2orf66

protein C2orf66: A potential drug target and biomarker

Abstract:
C2orf66 is a highly conserved protein that has been identified as a potential drug target and biomarker. It is a key regulator of the cytoskeleton and plays a critical role in the development and maintenance of neural stem cells. This article discusses the current understanding of C2orf66, its potential drug target implications, and its potential as a biomarker for various diseases.

Introduction:
Cytoskeleton is a complex network of filaments and proteins that provides structural support to cells and plays a critical role in cell division, migration, and cytokinesis. The cytoskeleton is composed of a variety of proteins, including histones, microtubules, and other non-histone proteins . One of these proteins, C2orf66, has been identified as a potential drug target and biomarker.

C2orf66: A conserved protein that regulates cytoskeleton development and maintenance

C2orf66 is a 21-kDa protein that is highly conserved across various species, including humans, mouse, and worm. It is located in the N-terminus of the alpha-tubulin protein and is part of the microtubule organizing protein (MT) family . MT proteins are involved in the regulation of microtubule dynamics and stability, which is critical for the proper functioning of the cytoskeleton.

C2orf66 is involved in the regulation of several critical events in cell development and maintenance, including the establishment and maintenance of neural stem cells (NSCs). NSCs are a type of pluripotent cell that have the potential to differentiate into any cell type in the adult body . The regulation of NSCs is critical for the development and maintenance of tissues and organs, including the brain and spinal cord.

C2orf66 is a key regulator of the cytoskeleton and plays a critical role in the development and maintenance of NSCs. It is involved in the regulation of microtubule dynamics and stability, which is critical for the proper functioning of the cytoskeleton.

Potential drug target implications

C2orf66 has been identified as a potential drug target due to its unique structure and its involvement in several critical events in cell development and maintenance. One of the potential drug targets for C2orf66 is the regulation of the cytoskeleton, which is critical for the proper functioning of cells and tissues.

Another potential drug target for C2orf66 is the regulation of stem cell maintenance and proliferation. As discussed above, NSCs are a type of pluripotent cell that have the potential to differentiate into any cell type in the adult body. The regulation of NSCs is critical for the development and maintenance of tissues and organs, including the brain and spinal cord.

In addition, C2orf66 may also be a potential drug target for the regulation of cell division and the progression of cancer. The regulation of cell division is critical for the growth and development of cells, and changes in cell division rates can contribute to the development and progression of cancer.

Potential biomarker implications

C2orf66 has also been identified as a potential biomarker for several diseases, including neurodegenerative diseases, cancer, and autoimmune diseases.

In neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, the regulation of NSCs and the cytoskeleton is critical for the development and maintenance of healthy neural stem cells. Therefore, changes in the regulation of NSCs and the cytoskeleton have

Protein Name: Chromosome 2 Open Reading Frame 66

The "C2orf66 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C2orf66 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets